CSIMarket
 


Beyond Air Inc   (XAIR)
Other Ticker:  
 

Cumulative Beyond Air Inc 's Working Capital Ratio for Trailing Twelve Months Period

XAIR's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth


Select the Comparisons : Select the Ratio:

XAIR Working Capital Ratio for Trailing Twelve Months Period

(Dec 31 2023)
III. Quarter
(Sep 30 2023)
II. Quarter
(Jun 30 2023)
I. Quarter
(Mar 31 2023)
IV. Quarter
(Dec 31 2022)
III. Quarter
Y / Y Current Liabilities Growth 0.38 % 7.38 % 18.27 % 84.65 % 87.71 %
Y / Y Current Assets Growth -40.26 % -37.22 % -25.83 % -36.08 % -30.28 %
Working Capital Ratio for Trailing Twelve Months Period 3.75 4.22 4.8 5.38 7.25
Total Ranking # 494 # 830 # 777 # 772 # 635
Seq. Current Liabilities Growth -6.53 % 3.65 % -39.25 % 70.56 % -0.01 %
Seq. Current Assets Growth -16.33 % -25.61 % 6.65 % -10.01 % -12.07 %


Working Capital Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2023
On the trailing twelve months basis Due to decrease in Current Liabilities in the III. Quarter to $12 millions, average cumulative Working Capital Ratio for Trailing Twelve Months Period decreased to 3.75 below Beyond Air Inc average Working Capital Ratio for Trailing Twelve Months Period.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Medical Equipment & Supplies industry 55 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than Beyond Air Inc . While overall ranking remained unchanged compare to previous quarter at no. .

What is Working Capital Ratio?
More about XAIR
Working Capital Ratio XAIR in the most recent quarter
Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 56
Sector # 253
S&P 500 # 580


Working Capital Ratio for Trailing Twelve Months Period Statistics
High Average Low
10.44 5.54 1.98
(Dec 31 2021)   (Sep 30 2019)




Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2023, within Medical Equipment & Supplies Industry Working Capital Ratio for Trailing Twelve Months Period
Akili Inc   9.90 
Silk Road Medical Inc   9.70 
Rxsight Inc   9.60 
Neuropace Inc   9.31 
Femasys Inc   9.21 
Si bone inc   9.18 
Pulse Biosciences Inc   9.17 
Iradimed Corporation  9.09 
Semler Scientific Inc   9.08 
Fonar Corporation  8.99 
Axonics Inc   8.93 
Shockwave Medical Inc   8.78 
Retractable Technologies inc   8.51 
Inspire Medical Systems inc   8.27 
Pulmonx Corporation  8.18 
Procept Biorobotics Corporation  7.98 
The Beauty Health Company  7.90 
Sensus Healthcare Inc   7.76 
Sonendo Inc   7.71 
Orchestra Biomed Holdings Inc   7.42 
Helius Medical Technologies inc   7.38 
Avita Medical Inc   7.18 
Brainsway Ltd   7.14 
Inspira Technologies Oxy B h n Ltd   7.02 
Rewalk Robotics Ltd   6.95 
Nevro Corp   6.93 
Atrion Corporation  6.92 
Orasure Technologies Inc  6.86 
Icecure Medical Ltd   6.75 
Heartbeam Inc   6.74 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com